• Live
    • Audio Only
  • google plus
  • facebook
  • twitter
  • BioCubaFarma facilities in Cuba, August, 2020.

    BioCubaFarma facilities in Cuba, August, 2020. | Photo: Twitter/ @CubaStandard

Published 11 August 2020
Opinion

Before being tested in 76 volunteers, the "Sputnik V" passed all the safety and efficacy tests.

Russia's Direct Investment Fund (RDIF) Chief Executive Officer Kiril Dmitriev announced that Cuba could begin producing the COVID-19 vaccine, the Sputnik V, in November.

RELATED:

Russia Registers the World's First COVID-19 Vaccine

“Cuba has a large capacity to produce medicines and vaccines with highly qualified staff. We could coordinate with its government to start the vaccine production in November,” Dmitriev stated.

He also pointed out that the third stage of vaccine trials will begin in Russia on Wednesday. Later the United Arab Emirates, Saudi Arabia, and the Philippines will continue testing it.

On Tuesday, Health Minister Mikhail Murashko announced the registration of the world's first COVID-19 vaccine, the Sputnik V, which is named after the first artificial satellite launched into orbit by the USSR in 1957.

Before being tested in 76 volunteers, the Russian COVID-19 vaccine passed all the necessary safety and efficacy tests in several animal species.

On Tuesday morning, outlet Sputnik reported that that the Russian vaccine, which was developed by the Gamaleya Research Institute, can protect a person from the coronavirus for up to two years after injection.

"Such a prolonged period of protection is possible due to the vaccine being based on viral vectors – a harmless human adenovirus delivers a portion of the COVID-19 virus to a human body forcing it to form an immune response to it," the Russian outlet explained.

Comment
0
Comments
Post with no comments.